Table 1. How and why we should strive for fairness in academic publication on behalf of a variety of stakeholders.
Stakeholder | Aspirations and rationale for fairness in academic publishing |
---|---|
Authors | • Reducing delays in publication to advance progress of individuals, teams, and the global
scientific community; • Relaxing stringent formatting requirements to make the process less restrictive, onerous and time-consuming; • Optimizing peer review (e.g. open access reviewers, ensuring reviewers have appropriate expertise, minimising delay); • Providing open access portals, allowing work to be disseminated, used and cited widely; • Embracing diversity of output, including encouraging publication of negative results, experimental protocols, and unfinished datasets; • Reducing barriers to researchers in resource-limited settings; • Optimizing communication with publishers to make the process collaborative and efficient, and to drive ongoing improvements. |
Publishers | • Representing publishers as an essential component of the process of data dissemination,
and recognizing their role as a major driver for innovation; • Enhancing dialogue around cost; making data dissemination cost-effective while maintaining the viability of publishing businesses; • Developing a wider repertoire of output in order to meet the requirements of academia; • Optimizing communication with academia to make the process collaborative and efficient, and to drive ongoing improvements; • Identifying ‘predatory’ journals as harmful, and removing these from the academic record. |
Funders and academic
institutions |
• Providing full and timely recognition of scientific output hosted or funded by specific
agencies; • Developing opportunities for repositories of work produced by their researchers; • Providing feedback to stakeholders and investors; • Enhancing potential for collaboration; • Driving opportunities for innovation and translational output. |
Reviewers | • Ensuring that reviewers have sufficient and appropriate expertise;
• Providing formal credit and recognition of the contribution of reviewers. |
Patients | • Acknowledging and rewarding the commitment and altruism of patients who enroll in
clinical research; • Making results and conclusions of scientific research available to patients, their health- care teams, and those who allocate resources; • Avoiding harm through suppression of negative results. |
Public | • Assuring accountability of public money;
• Engaging and educating the public about science; • Adding to the resources available to educational institutions; • Making data available to other relevant agencies (e.g. the government, the media, economists, biotechnology). |